These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14979609)

  • 1. Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial.
    Rossi S; Tazza R
    Arzneimittelforschung; 2004; 54(1):50-6. PubMed ID: 14979609
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
    Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections.
    Macchi A; Vecchia LD
    Arzneimittelforschung; 2005; 55(5):276-81. PubMed ID: 15960427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation trial of respiratory bacterial prophylaxis by a ribosomal vaccine. Multicentric double blind study.
    Fumex JP; Michel FB
    Arzneimittelforschung; 1980; 30(1a):206-13. PubMed ID: 6989376
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immune preparation IRS-19 in the treatment of inflammation in the upper respiratory tracts].
    Gunchikov MV; Vinnikov AK
    Vestn Otorinolaringol; 2001; (1):40. PubMed ID: 11247247
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind study.
    Rutishauser M; Pitzke P; Grevers G; van Aubel A; Elsasser U; Kämmereit A
    Adv Ther; 1998; 15(6):330-41. PubMed ID: 10351117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of recurrent infection of the upper and lower airways. Multicenter, open study over three months].
    Debelic M; Eckenberger HP
    Fortschr Med; 1992 Nov; 110(30):565-70. PubMed ID: 1468743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation.
    Riedl-Seifert RJ; van Aubel A; Kämmereit A; Elsasser U
    Adv Exp Med Biol; 1995; 371B():799-802. PubMed ID: 7502900
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic stimulation in prevention of bacterial respiratory infection. Trial objective evaluation by changes in serum and sputum Ig(A and G)].
    Michel FB; d'Hinterland LD; Pinel AM; Guendon R; Guerrero A; Préault M
    Nouv Presse Med; 1975 Feb; 4(5):333-6. PubMed ID: 1093123
    [No Abstract]   [Full Text] [Related]  

  • 10. Multicentric study of the effectiveness of ribosomal vaccine (D 53) in the prevention of episodes of bacterial infection encountered in ENT pathology.
    Charachon R; Lavillauroy PJ; Fumex JP
    Arzneimittelforschung; 1980; 30(1a):214-20. PubMed ID: 6892781
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral administration of "Infectvac" for prevention of acute respiratory tract infections].
    Luther P; Brachmann I; Werchan D; Wittig C; Tischner H
    Z Erkr Atmungsorgane; 1990; 175(2):95-9. PubMed ID: 2264367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polybacterial immunostimulators in medical practice].
    Petrunov BP
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):122-6. PubMed ID: 15636158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of infections in chronic bronchitis using vaccination and/or immunomodulation].
    Latil F; Arnaud A; Lagier F; Charpin J; Vervloet D
    Rev Mal Respir; 1988; 5(1):31-5. PubMed ID: 3368632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broncho-vaxom in the treatment and prophylaxis of recurrent respiratory tract infections in bronchial asthma.
    Chyrek-Borowska S; Moniuszko T; Szymański W; Rogalewska A
    Pneumonol Alergol Pol; 1992; 60 Suppl 2():117-9. PubMed ID: 1305486
    [No Abstract]   [Full Text] [Related]  

  • 15. [Forced microbial stimulation in respiratory infections].
    Filip V; Brezeanu A; Ionescu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(4):369-72. PubMed ID: 2879341
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of bacterial respiratory infection by a new vaccine, an association of bacterial ribosomes and membranous adjuvants. 1. General remarks.
    Michel FB; Dussourd d'Hinterland L
    Arzneimittelforschung; 1980; 30(1a):196-8. PubMed ID: 6892779
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention and treatment of upper respiratory tract infections with IRS-19 and polydex with phenylephrine].
    Luchikhin LA; Beliakova LV; Gurov AV
    Vestn Otorinolaringol; 2000; (4):54-7. PubMed ID: 11011582
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prospective placebo-controlled double-blind study using a bacterial lysate in infections of the respiratory tract and ENT region in children].
    Schaad UB; Farine JC; Fux T
    Helv Paediatr Acta; 1986 May; 41(1-2):7-17. PubMed ID: 3755127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunologic indicators in the treatment of recurrent respiratory diseases using peroral bacterial vaccines].
    Kapellerová A; Sulko M; Krovinová A; Jakubovská M; Michalicková J; Mazáriková O
    Cesk Pediatr; 1989 Aug; 44(8):454-8. PubMed ID: 2791096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally administered bacterial lysate Broncho-Vaxom for the treatment of common variable immunodeficiency.
    Litzman J; Lokaj J; Gerylovova A
    Allerg Immunol (Paris); 1996 Mar; 28(3):81-5. PubMed ID: 8703313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.